Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Combination therapy Maxamine/IL-2 effective in extending remission time & preventing relapse

Oct. 4, 1996

Progenics cancer vaccine enters clinical trials

Oct. 4, 1996

Novopharm develops new recombinant form of MAb

Oct. 4, 1996

Cel-Sci's Multikine to be tested clinically at additional centers

Sep. 27, 1996

IL-2 receptor-binding polypeptide described by Boehringer Ingelheim

Sep. 13, 1996

Additional patent coverage for Maxim anticancer combination

Sep. 6, 1996

AltaRex and Medac finalize Ovarex partnership

Aug. 30, 1996

Imutec/NaPro BioTherapeutics sign research agreement

Aug. 23, 1996

C242-DM1: Promising new approach to colorectal cancer treatment

Aug. 23, 1996

MDX-210 efficacy/safety trial begins in U.K.

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.